Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD

Thorax

Volumn 67, Issue 1, 2012, Pages 26-34

  Lewis, Amy ^a   Riddoch Contreras, Joanna ^a   Natanek, Samantha A ^b   Donaldson, Anna ^a,b   Man, William D C ^b   Moxham, John ^c   Hopkinson, Nicholas S ^b   Polkey, Michael I ^b   Kemp, Paul R ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 4; MICRORNA; MICRORNA 1; MICRORNA 133; MICRORNA 206; MYOCARDIN; MYOCARDIN RELATED TRANSCRIPTION FACTOR A; MYOCARDIN RELATED TRANSCRIPTION FACTOR B; MYOSIN HEAVY CHAIN; PROTEIN KINASE B; SERUM RESPONSE FACTOR; SOMATOMEDIN C; UNCLASSIFIED DRUG;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; HUMAN; HUMAN TISSUE; LUNG FUNCTION; MALE; MUSCLE BIOPSY; MUSCLE FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; QUADRICEPS FEMORIS MUSCLE; SIGNAL TRANSDUCTION; SMOKING;

EID: 84855201605     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2011-200309     Document Type: Article

References (43)

1. Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007;62:115-20.
2. Marquis K, Debigaré R, Lacasse Y, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:809-13.
3. Seymour JM, Spruit MA, Hopkinson NS, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 2010;36:81-8.
4. Allaire J, Maltais F, Doyon JF, et al. Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax 2004;59:673-8. (Pubitemid 39061530)
5. Gosker HR, Zeegers MP, Wouters EF, et al. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax 2007;62:944-9. (Pubitemid 350084491)
6. Williams AH, Liu N, van Rooij E, et al. MicroRNA control of muscle development and disease. Curr Opin Cell Biol 2009;21:461-9.
7. Nakajima N, Takahashi T, Kitamura R, et al. MicroRNA-1 facilitates skeletal myogenic differentiation without affecting osteoblastic and adipogenic differentiation. Biochem Biophys Res Commun 2006;350:1006-12. (Pubitemid 44584193)
8. Williams AH, Valdez G, Moresi V, et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009;326:1549-54.
9. van Rooij E, Quiat D, Johnson BA, et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 2009;17:662-73.
10. McCarthy JJ, Esser KA, Peterson CA, et al. Evidence of MyomiR network regulation of beta-myosin heavy chain gene expression during skeletal muscle atrophy. Physiol Genomics 2009;39:219-26.
11. Chen JF, Mandel EM, Thomson JM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006;38:228-33. (Pubitemid 43177239)
12. Eisenberg I, Eran A, Nishino I, et al. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A 2007;104:17016-21. (Pubitemid 350210983)
13. Gallagher IJ, Scheele C, Keller P, et al. Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med 2010;2:9.
14. Keller P, Vollaard NB, Gustafsson T, et al. A transcriptional map of the impact of endurance exercise training on skeletal muscle phenotype. J Appl Physiol 2011;110:46-59.
15. Jeng SF, Rau CS, Liliang PC, et al. Profiling muscle-specific microRNA expression after peripheral denervation and reinnervation in a rat model. J Neurotrauma 2009;26:2345-53.
16. Rau CS, Jeng JC, Jeng SF, et al. Entrapment neuropathy results in different microRNA expression patterns from denervation injury in rats. BMC Musculoskelet Disord 2010;11:181.
17. Allen DL, Bandstra ER, Harrison BC, et al. Effects of spaceflight on murine skeletal muscle gene expression. J Appl Physiol 2009;106:582-95.
18. Davidsen PK, Gallagher IJ, Hartman JW, et al. High responders to resistance exercise training demonstrate differential regulation of skeletal muscle microRNA expression. J Appl Physiol 2011;110:309-17.
19. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005;436:214-20. (Pubitemid 41021266)
20. Niu Z, Iyer D, Conway SJ, et al. Serum response factor orchestrates nascent sarcomerogenesis and silences the biomineralization gene program in the heart. Proc Natl Acad Sci U S A 2008;105:17824-9.
21. Lamon S, Wallace MA, Leger B, et al. Regulation of STARS and its downstream targets suggest a novel pathway involved in human skeletal muscle hypertrophy and atrophy. J Physiol 2009;587:1795-803.
22. Wallace MA, Hock MB, Hazen BC, et al. Striated muscle activator of Rho signalling (STARS) is a PGC-1alpha/oestrogen-related receptor-alpha target gene and is upregulated in human skeletal muscle after endurance exercise. J Physiol 2011;589:2027-39.
23. Sakuma K, Akiho M, Nakashima H, et al. Age-related reductions in expression of serum response factor and myocardin-related transcription factor A in mouse skeletal muscles. Biochim Biophys Acta 2008;1782:453-61.
24. Allen DL, Weber JN, Sycuro LK, et al. Myocyte enhancer factor-2 and serum response factor binding elements regulate fast Myosin heavy chain transcription in vivo. J Biol Chem 2005;280:17126-34. (Pubitemid 41389177)
25. Elia L, Contu R, Quintavalle M, et al. Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 2009;120:2377-85.
26. Rosenberg MI, Georges SA, Asawachaicharn A, et al. MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206. J Cell Biol 2006;175:77-85. (Pubitemid 44537200)
27. Drummond MJ, Glynn EL, Fry CS, et al. Essential amino acids increase microRNA-499, -208b, and -23a and downregulate myostatin and myocyte enhancer factor 2C mRNA expression in human skeletal muscle. J Nutr 2009;139:2279-84.
28. Safdar A, Abadi A, Akhtar M, et al. miRNA in the regulation of skeletal muscle adaptation to acute endurance exercise in C57Bl/6J male mice. PLoS One 2009;4:e5610.
29. Lewis A, Riddoch-Contreras J, Natanek SA, et al. Alterations in MRTF and FHL1 activity contribute to fibre type shift in the quadriceps of patients with COPD. Am J Respir Crit Care Med 2010;181:A6611.
30. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55. (Pubitemid 47403272)
31. Ellis PD, Smith CW, Kemp P. Regulated tissue-specific alternative splicing of enhanced green fluorescent protein transgenes conferred by alpha-tropomyosin regulatory elements in transgenic mice. J Biol Chem 2004;279:36660-9. (Pubitemid 39129012)
32. Riddoch Contreras J, Sathyapala SA, Marsh GS, et al. Four and a half LIM protein 1 expression and akt phosphorylation in quadriceps muscle in chronic obstructive pulmonary disease patients and its relation to muscle strength and physical activity. Thorax 2008;63:A24.
33. Yu XY, Song YH, Geng YJ, et al. Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1. Biochem Biophys Res Commun 2008;376:548-52.
34. Hua Y, Zhang Y, Ren J. IGF-1 deficiency resists cardiac hypertrophy and myocardial contractile dysfunction: role of microRNA-1 and microRNA-133a. J Cell Mol Med. Published Online First: 21 March 2011. doi:10.1111/j.1582-4934.2011. 01307.x.
35. Shan ZX, Lin QX, Fu YH, et al. Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction. Biochem Biophys Res Commun 2009;381:597-601.
36. Sun Y, Ge Y, Drnevich J, et al. Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis. J Cell Biol 2010;189:1157-69.
37. Ikeda S, He A, Kong SW, et al. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol 2009;29:2193-204.
38. Debigare R, Maltais F, Cote CH, et al. Profiling of mRNA expression in quadriceps of patients with COPD and muscle wasting. COPD 2008;5:75-84. (Pubitemid 351549830)
39. Doucet M, Russell AP, Leger B, et al. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;176:261-9. (Pubitemid 47195876)
40. Selvaraj A, Prywes R. Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum response factor, is required for skeletal myogenic differentiation. J Biol Chem 2003;278:41977-87. (Pubitemid 37310461)
41. Giger JM, Bodell PW, Zeng M, et al. Rapid muscle atrophy response to unloading: pretranslational processes involving MHC and actin. J Appl Physiol 2009;107:1204-12.
42. Nielsen S, Scheele C, Yfanti C, et al. Muscle specific microRNAs are regulated by endurance exercise in human skeletal muscle. J Physiol 2010;588:4029-37.
43. Man WDC, Natanek SA, Riddoch-Contreras J, et al. Quadriceps myostatin expresssion in COPD. Eur Respir J 2010;36:686-9.